Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1949 2
1950 3
1951 10
1952 8
1953 26
1954 23
1955 42
1956 48
1957 67
1958 64
1959 61
1960 52
1961 62
1962 52
1963 90
1964 115
1965 91
1966 133
1967 155
1968 261
1969 330
1970 392
1971 443
1972 502
1973 536
1974 676
1975 676
1976 774
1977 769
1978 763
1979 780
1980 822
1981 758
1982 761
1983 678
1984 736
1985 683
1986 692
1987 636
1988 638
1989 548
1990 571
1991 525
1992 487
1993 486
1994 450
1995 457
1996 426
1997 419
1998 410
1999 361
2000 352
2001 366
2002 400
2003 355
2004 419
2005 373
2006 281
2007 253
2008 256
2009 237
2010 264
2011 263
2012 253
2013 296
2014 322
2015 315
2016 324
2017 312
2018 300
2019 254
2020 284
2021 276
2022 326
2023 299
2024 240
2025 97

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26,445 results

Results by year

Filters applied: . Clear all
Page 1
100 years of glucagon and 100 more.
Wewer Albrechtsen NJ, Holst JJ, Cherrington AD, Finan B, Gluud LL, Dean ED, Campbell JE, Bloom SR, Tan TM, Knop FK, Müller TD. Wewer Albrechtsen NJ, et al. Diabetologia. 2023 Aug;66(8):1378-1394. doi: 10.1007/s00125-023-05947-y. Epub 2023 Jun 27. Diabetologia. 2023. PMID: 37367959 Review.
The New Biology and Pharmacology of Glucagon.
Müller TD, Finan B, Clemmensen C, DiMarchi RD, Tschöp MH. Müller TD, et al. Physiol Rev. 2017 Apr;97(2):721-766. doi: 10.1152/physrev.00025.2016. Physiol Rev. 2017. PMID: 28275047 Free article. Review.
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept.
Coskun T, Urva S, Roell WC, Qu H, Loghin C, Moyers JS, O'Farrell LS, Briere DA, Sloop KW, Thomas MK, Pirro V, Wainscott DB, Willard FS, Abernathy M, Morford L, Du Y, Benson C, Gimeno RE, Haupt A, Milicevic Z. Coskun T, et al. Cell Metab. 2022 Sep 6;34(9):1234-1247.e9. doi: 10.1016/j.cmet.2022.07.013. Epub 2022 Aug 18. Cell Metab. 2022. PMID: 35985340 Free article.
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA.
Rosenstock J, Frias J, Jastreboff AM, Du Y, Lou J, Gurbuz S, Thomas MK, Hartman ML, Haupt A, Milicevic Z, Coskun T. Rosenstock J, et al. Lancet. 2023 Aug 12;402(10401):529-544. doi: 10.1016/S0140-6736(23)01053-X. Epub 2023 Jun 26. Lancet. 2023. PMID: 37385280 Clinical Trial.
A famsin-glucagon axis mediates glucose homeostasis.
Long A, Wang Y, Guo Y, Hong J, Ning G, Meng Z, Wang J, Wang Y. Long A, et al. Cell Metab. 2025 Mar 4;37(3):629-639.e6. doi: 10.1016/j.cmet.2024.11.008. Epub 2024 Dec 19. Cell Metab. 2025. PMID: 39706194
Negative allosteric modulation of the glucagon receptor by RAMP2.
Krishna Kumar K, O'Brien ES, Habrian CH, Latorraca NR, Wang H, Tuneew I, Montabana E, Marqusee S, Hilger D, Isacoff EY, Mathiesen JM, Kobilka BK. Krishna Kumar K, et al. Cell. 2023 Mar 30;186(7):1465-1477.e18. doi: 10.1016/j.cell.2023.02.028. Cell. 2023. PMID: 37001505 Free PMC article.
26,445 results
You have reached the last available page of results. Please see the User Guide for more information.